BPA -quotient blood products
Ended Awarded Last action
- Contract number
- 36C25625N0104
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,203
Award facts
- Contract value 100% obligated
- $12,203.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$358 | |
| Supplemental Agreement for work within scope | -$197 | |
| Original award | $12,758 |
About this award
Alba Bioscience, Inc., a Chicago-based manufacturer of blood bank reagents and in vitro diagnostic products, received a BPA call award from Veterans Integrated Service Network 16 (VISN 16) on October 1, 2024, with a ceiling value of $12,203.10 and a completion date of September 30, 2025. This firm fixed price contract award utilizes the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests and represents a task order under Alba Bioscience's existing Blanket Purchase Agreement with the Department of Veterans Affairs. The contract carries no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of critical blood banking and diagnostic materials to federal healthcare systems. Performance will be completed in Chicago, Illinois.
Alba Bioscience specializes in delivering immunohematology products including antibody screening cells, antibody identification panels, blood typing reagents, and quality control materials essential for laboratory operations across VA medical facilities. The company, a subsidiary of Quotient Biodiagnostics, Inc., has established a substantial presence within the federal healthcare procurement landscape through multiple VA contracts and agreements with the Defense Logistics Agency and National Institutes of Health. This contract supports the VA's mission to provide specialized diagnostic and blood banking capabilities to veteran healthcare systems by ensuring consistent access to high-quality reagents and testing materials required for immunohematology and transfusion medicine operations.
Quick answers
Who was awarded contract 36C25625N0104?
36C25625N0104 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C25625N0104 worth?
The government has obligated $12,203 on 36C25625N0104.
Is contract 36C25625N0104 an order under another contract?
Yes. 36C25625N0104 is a BPA call under V797P2050D-36C25621A0012, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25625N0104 competed?
The extent of competition for 36C25625N0104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award